213 related articles for article (PubMed ID: 1358986)
1. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
J Infect Dis; 1992 Dec; 166(6):1223-7. PubMed ID: 1358986
[TBL] [Abstract][Full Text] [Related]
2. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression.
Hoover DR; Peng Y; Saah A; Semba R; Detels RR; Rinaldo CR; Phair JP
Arch Ophthalmol; 1996 Jul; 114(7):821-7. PubMed ID: 8660165
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus retinitis in patients with AIDS in Europe. AIDS in Europe Study Group.
Burke M; Yust I; Katlama C; Vardinon N; Clumeck N; Pinching AJ; Ledergerber B; Gatell JM; Chiesi A; Barton SE; Lundgren JD; Pedersen C
Eur J Clin Microbiol Infect Dis; 1997 Dec; 16(12):876-82. PubMed ID: 9495667
[TBL] [Abstract][Full Text] [Related]
6. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
Moore RD; Keruly J; Richman DD; Creagh-Kirk T; Chaisson RE
AIDS; 1992 Jul; 6(7):671-7. PubMed ID: 1503686
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of occurrence of cytomegalovirus disease and impact on survival in the Aquitaine Cohort in France, 1985 to 1994. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
Saillour F; Bernard N; Dequae-Merchadou L; Marimoutou C; Journot V; Dabis F
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):171-8. PubMed ID: 9473020
[TBL] [Abstract][Full Text] [Related]
9. Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study Group.
Glesby MJ; Moore RD; Chaisson RE
J Infect Dis; 1993 Nov; 168(5):1264-8. PubMed ID: 8228361
[TBL] [Abstract][Full Text] [Related]
10. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
11. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus.
Pertel P; Hirschtick R; Phair J; Chmiel J; Poggensee L; Murphy R
J Acquir Immune Defic Syndr (1988); 1992; 5(11):1069-74. PubMed ID: 1357151
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of cytomegalovirus in patients with advanced HIV disease: influence on disease expression and survival.
Shepp DH; Moses JE; Kaplan MH
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):460-8. PubMed ID: 8605591
[TBL] [Abstract][Full Text] [Related]
13. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus colitis in HIV-1-infected patients: a prospective research in 55 patients.
Mentec H; Leport C; Leport J; Marche C; Harzic M; Vildé JL
AIDS; 1994 Apr; 8(4):461-7. PubMed ID: 8011249
[TBL] [Abstract][Full Text] [Related]
15. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.
Easterbrook PJ; Keruly JC; Creagh-Kirk T; Richman DD; Chaisson RE; Moore RD
JAMA; 1991 Nov; 266(19):2713-8. PubMed ID: 1942423
[TBL] [Abstract][Full Text] [Related]
16. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
Martin BK; Ricks MO; Forman MS; Jabs DA;
Clin Infect Dis; 2007 Apr; 44(7):1001-8. PubMed ID: 17342657
[TBL] [Abstract][Full Text] [Related]
17. Treatment with corticosteroids--a risk factor for the development of clinical cytomegalovirus disease in AIDS.
Nelson MR; Erskine D; Hawkins DA; Gazzard BG
AIDS; 1993 Mar; 7(3):375-8. PubMed ID: 8097096
[TBL] [Abstract][Full Text] [Related]
18. Zidovudine therapy, CD4+ and CD8+ counts are associated with a longer survival following AIDS onset.
Fiala M; Swartz J; Teklehaimanot S; Kermani V; Funnye AS; Sayre JW; Gornbein JA
Lymphology; 1997 Sep; 30(3):128-36. PubMed ID: 9313205
[TBL] [Abstract][Full Text] [Related]
19. CMV disease in AIDS patients: incidence of CMV disease and relation to survival in a population-based study from Oslo.
Brantsaeter AB; Liestøl K; Goplen AK; Dunlop O; Bruun JN
Scand J Infect Dis; 2002; 34(1):50-5. PubMed ID: 11874165
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus retinitis under combination therapy with zidovudine and dideoxycytidine in advanced human immunodeficiency virus infection.
Kaulen P; Pham DT; Baranowski E; Wollensak J
Ger J Ophthalmol; 1993 Nov; 2(6):412-5. PubMed ID: 8312826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
